Sumitomo Dainippon Pharma
4506.T
#3015
Rank
$3.12 B
Marketcap
$7.87
Share price
1.20%
Change (1 day)
-38.71%
Change (1 year)

P/E ratio for Sumitomo Dainippon Pharma (4506.T)

P/E ratio as of November 2022 (TTM): 9.45

According to Sumitomo Dainippon Pharma 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 9.45208. At the end of 2022 the company had a P/E ratio of 8.75.

P/E ratio history for Sumitomo Dainippon Pharma from 2009 to 2022

PE ratio at the end of each year

Year P/E ratio Change
20228.75-38.05%
202114.10.45%
202014.1-37.39%
201922.569.13%
201813.3-49.25%
201726.224.23%
201621.1-43.14%
201537.016.51%
201431.8-51.5%
201365.562.33%
201240.4133.8%
201117.36.55%
201016.2-1.89%
200916.516.01%
200814.2-35.68%
200722.1-8.53%
200624.2-2.52%
200524.8

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.